February 2017 Current Affairs
24 FEB
NEWS
23 FEB
NEWS
22 FEB
NEWS
21 FEB
NEWS
20 FEB
NEWS
18 FEB
NEWS

January 2017 Current Affairs
31 JAN
NEWS
30 JAN
NEWS
28 JAN
NEWS
27 JAN
NEWS
25 JAN
NEWS
24 JAN
NEWS

December 2016 Current Affairs
31 DEC
NEWS
30 DEC
NEWS
29 DEC
NEWS
28 DEC
NEWS
27 DEC
NEWS
26 DEC
NEWS

November 2016 Current Affairs
30 NOV
NEWS
29 NOV
NEWS
28 NOV
NEWS
26 NOV
NEWS
25 NOV
NEWS
24 NOV
NEWS

October 2016 Current Affairs
31 OCT
NEWS
27 OCT
NEWS
26 OCT
NEWS
25 OCT
NEWS
24 OCT
NEWS
22 OCT
NEWS

Sun Pharma to acquire 85% stake in Russia’s Biosintez for $60 million

Sun Pharma to acquire 85% stake in Russia’s Biosintez for $60 million
24 November 2016 Current Affairs: India’s largest drug maker Sun Pharma, facing an uncertain US market over pricing issues, launched an attempt to move into emerging markets and announced has the acquisition of Biosintez, a Russian company making and marketing pharmaceutical products in the Common Wealth of Independent Countries. 

Sun Pharma picked up 85.1% of the company for US$ 24 million and also the debt of approximately US$ 36 million as part of the transaction. Biosintez is a Russian pharmaceutical company focusing on the hospital segment with annual revenues of approximately US$ 52 million for 2015 .

It has a manufacturing facility in Penza region with capabilities to manufacture a wide variety of dosage forms including pharmaceuticals for injections, blood substitutes, blood preservatives, ampoules, tablets, ointment, creams, gels, suppositories and APIs. 

Emerging markets have become a much needed growth driver for large companies like Sun Pharma and Dr Reddy’s who have been reeling under regulatory flak in US markets for quality issues and price hikes. The acquisition in Russia also comes as part of the mandatory 2020 plan of localization in Russia that stipulates companies to have a local base in the country. 

Though hit by the currency fluctuation, the $10-billion Russian market is a pull for Indian drug companies. For the quarter ended September 2016, Sun Pharma consolidated profit was up 90.2% yearon-year to Rs 2,471 crore in the quarter ended September 2016, Sun Pharma’s manufacturing units at Halol is under investigation from the USFDA, besides the Department of Justice that is looking at price hikes by generic companies. On Wednesday, Sun pharma’s shares rose 1.64% to close at Rs 701, though a year ago the shares of Sun Pharma were trading at Rs 718 around the same date. 

 


February 2017 Current affairs
24 FEB
NEWS
23 FEB
NEWS
22 FEB
NEWS
21 FEB
NEWS
20 FEB
NEWS
18 FEB
NEWS

January 2017 Current affairs
31 JAN
NEWS
30 JAN
NEWS
28 JAN
NEWS
27 JAN
NEWS
25 JAN
NEWS
24 JAN
NEWS




December 2016 Current affairs
31 DEC
NEWS
30 DEC
NEWS
29 DEC
NEWS
28 DEC
NEWS
27 DEC
NEWS
26 DEC
NEWS

November 2016 Current affairs
30 NOV
NEWS
29 NOV
NEWS
28 NOV
NEWS
26 NOV
NEWS
25 NOV
NEWS
24 NOV
NEWS

October 2016 Current affairs
31 OCT
NEWS
27 OCT
NEWS
26 OCT
NEWS
25 OCT
NEWS
24 OCT
NEWS
22 OCT
NEWS



FreshersLive - No.1 Job site in India. Fresherslive Current Affairs 2017 section offers informative quiz questions with answers regarding latest current affairs today for all sorts of competitive exams like UPSC, TNPSC , IFS, IAS, IPS, railway exams (RRB) and banking exams like IPBS PO, IPBS clerk, Federal Bank PO, ICICI, SBI, RBI legal officer & Grade officer posts and much more. Register with us to get latest Current Affairs Updates. Also get latest Current Affairs news and quiz Updates for free alerts daily through E-mail

Get Daily Current Affairs to your Email

You can Unsubscribe us at any time.

Get Daily Current Affairs to your Email

You can Unsubscribe us at any time.